Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives
暂无分享,去创建一个
A. Deep | Metab Alharbi | Abdulrahman Alshammari | Hitesh Chopra | S. Bibi | H. Kumar | D. Kumar | Navidha Aggarwal | Virender Kumar | Abdul Hayee | Rakesh Kumar Marwaha | M. Alharbi | A. Alshammari
[1] Adrian V. Lee,et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis , 2022, Nature Cancer.
[2] S. Paliwal,et al. Diverse Biological Activities of 1,3,4-Thiadiazole Scaffold , 2022, Chemistry.
[3] A. Deep,et al. Mechanism-based approaches of 1,3,4 thiadiazole scaffolds as potent enzyme inhibitors for cytotoxicity and antiviral activity , 2022, Medicine in Drug Discovery.
[4] A. Deep,et al. Thiazolidin-2,4-Dione Scaffold: An Insight into Recent Advances as Antimicrobial, Antioxidant, and Hypoglycemic Agents , 2022, Molecules.
[5] N. Jain,et al. Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors , 2022, BMC Chemistry.
[6] A. Deep,et al. 1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif , 2022, Cancer Advances.
[7] Hybrids of Thiazolidin-4-Ones and 1,3,4-Thiadiazole: Synthesis and Biological Screening of A Potential New Class of Acetylcholinesterae Inhibitors , 2021, Biointerface Research in Applied Chemistry.
[8] G. Nițulescu,et al. Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives , 2021, Pharmaceuticals.
[9] T. Bohn,et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? , 2021, Antioxidants.
[10] Handbook of Oxidative Stress in Cancer: Therapeutic Aspects , 2021 .
[11] V. Mohanlall,et al. Design, synthesis and characterization of novel 2-(2, 3-dichlorophenyl)-5-aryl-1,3,4-oxadiazole derivatives for their anti-tubercular activity against Mycobacterium tuberculosis , 2020 .
[12] M. Sharifi-Rad,et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases , 2020, Frontiers in Physiology.
[13] K. Ayub,et al. Synthesis, crystal structures, computational studies and α-amylase inhibition of three novel 1,3,4-oxadiazole derivatives , 2020 .
[14] M. Gnant,et al. Breast cancer , 2019, Nature Reviews Disease Primers.
[15] R. Marwaha,et al. Oxadiazole-An Important Bioactive Scaffold for Drug Discovery and Development Process Against HIV and Cancer- A Review , 2019, Current Bioactive Compounds.
[16] Jun Zhang,et al. Role of ROS and Nutritional Antioxidants in Human Diseases , 2018, Front. Physiol..
[17] Bo Liu,et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis , 2018, Genes & diseases.
[18] Basappa,et al. Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells , 2018, Front. Oncol..
[19] J. Sangshetti,et al. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti‐tubercular agents , 2018, Archiv der Pharmazie.
[20] A. Bitto,et al. Oxidative Stress: Harms and Benefits for Human Health , 2017, Oxidative medicine and cellular longevity.
[21] Ruth Etzioni,et al. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[22] N. Subbarao,et al. In vivo anti-inflammatory activity and docking study of newly synthesized benzimidazole derivatives bearing oxadiazole and morpholine rings. , 2017, Bioorganic chemistry.
[23] Navkiran K. Shokar,et al. Breast Cancer Epidemiology, Prevention, and Screening. , 2017, Progress in molecular biology and translational science.
[24] T. Kaoud,et al. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities. , 2016, Bioorganic chemistry.
[25] S. Sugiharto,et al. Assay of Antioxidant Potential of Two Filamentous Fungi Isolated from the Indonesian Fermented Dried Cassava , 2016, Antioxidants.
[26] Ahmedin Jemal,et al. Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[27] Jie Wu,et al. Synthesis of 2-amino-1,3,4-oxadiazoles and 2-amino-1,3,4-thiadiazoles via sequential condensation and I2-mediated oxidative C–O/C–S bond formation. , 2015, The Journal of organic chemistry.
[28] S. Khanum,et al. Synthesis and evaluation of in vitro antioxidant properties of novel 2,5-disubstituted 1,3,4-oxadiazoles , 2014, Russian Journal of Bioorganic Chemistry.
[29] K. Mohana,et al. Synthesis and Evaluation of In Vivo Anticonvulsant Activity of 2, 5-Disubstituted-1, 3, 4-Oxadiazole Derivatives , 2013 .
[30] M. Abdollahi,et al. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. , 2013, Toxicology and applied pharmacology.
[31] M. Zarrindast,et al. Design, Synthesis and Anticonvulsant Activity of 2-(2-Phenoxy) phenyl- 1,3,4-oxadiazole Derivatives , 2013, Iranian journal of pharmaceutical research : IJPR.
[32] Jacqueline Cloos,et al. Cell sensitivity assays: the MTT assay. , 2011, Methods in molecular biology.
[33] B. Narasimhan,et al. Antimicrobial evaluation of 4-methylsulfanyl benzylidene/3-hydroxy benzylidene hydrazides and QSAR studies , 2012, Medicinal Chemistry Research.
[34] B. Narasimhan,et al. Benzylidene/2-chlorobenzylidene hydrazides: Synthesis, antimicrobial activity, QSAR studies and antiviral evaluation , 2010, European Journal of Medicinal Chemistry.
[35] P. G. Nayak,et al. A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1,3,4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and N(G)-nitro-l-arginine hypertensive rats. , 2010, Chemico-biological interactions.
[36] H. Kumar,et al. Synthesis of Some 1,3,4‐Oxadiazole Derivatives as Potential Antiinflammatory Agents. , 2007 .
[37] H. Kumar,et al. Synthesis of some 1,3,4-oxadiazole derivatives as potential anti-inflammatory agents , 2007 .
[38] J. Palmer,et al. Keto-1,3,4-oxadiazoles as cathepsin K inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[39] Mahmud Tareq Hassan Khan,et al. Structure-activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues. , 2005, Bioorganic & medicinal chemistry.